Purchase of Shares by Directors

About this update from Cambridge Nutritional Sciences Plc

  The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.     OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group")   Purchase of Shares by Directors   Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces the following Director purchases of, in aggregate, 819,181 ordinary shares in the Company:   Name Position Number of Ordinary Shares Purchased   Price per Ordinary Share Resultant Shareholding Percentage of Issued Share Capital Simon Douglas   Chairman   260,001 2.88p 760,001 +0.32% Jag Grewal   Chief Executive Officer   159,180 2.89p 894,926   +0.38% Chris Lea   Chief Financial Director   400,000 2.81p 900,000 +0.38%     Contacts:    Omega Diagnostics Group PLC  www.omegadx.com Jag Grewal, Chief Executive Officer  via Walbrook PR Chris Lea, Chief Financial Officer finnCap Ltd   Tel: 020 7220 0500 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) Alice Lane/ Charlotte Sutcliffe (ECM) Walbrook PR Limited Tel: 020 7933 8780 or [email protected] Paul McManus Mob: 07980 541 893   About Omega Diagnostics Group PLC Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health. www.omegadx.com       Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them   1.  Details of the person discharging managerial responsibilities / person closely associated a.  Name Simon Douglas 2.  Reason for the notification a.  Position/status Chairman a.  Initial notification /Amendment Initial notification 3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a.  Name Omega Diagnostics Group plc b.  LEI 2138007U9P4BTZTYIR92 4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a.  Description of the Financial instrument, type of instrument Identification code Ordinary Shares of 4 pence each    ISIN: GB00B1VCP282 b.  Nature of the transaction Purchase of Ordinary Shares  c.  Price(s) and volume(s) 2.88 pence 260,001 Ordinary Shares d.  Aggregated information · Aggregated volume · Price   N/A e.  Date of the transaction 15 September 2022 f.  Place of the transaction London Stock Exchange     1.  Details of the person discharging managerial responsibilities / person closely associated a.  Name Jag Grewal 2.  Reason for the notification a.  Position/status Chief Executive Officer a.  Initial notification /Amendment Initial notification 3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a.  Name Omega Diagnostics Group plc b.  LEI 2138007U9P4BTZTYIR92 4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a.  Description of the Financial instrument, type of instrument Identification code Ordinary Shares of 4 pence each    ISIN: GB00B1VCP282 b.  Nature of the transaction Purchase of Ordinary Shares  c.  Price(s) and volume(s) 2.89 pence 159,180 Ordinary Shares d.  Aggregated information · Aggregated volume · Price   N/A e.  Date of the transaction 15 September 2022 f.  Place of the transaction London Stock Exchange     1.  Details of the person discharging managerial responsibilities / person closely associated a.  Name Chris Lea 2.  Reason for the notification a.  Position/status Chief Financial Officer a.  Initial notification /Amendment Initial notification 3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a.  Name Omega Diagnostics Group plc b.  LEI 2138007U9P4BTZTYIR92 4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a.  Description of the Financial instrument, type of instrument Identification code Ordinary Shares of 4 pence each    ISIN: GB00B1VCP282 b.  Nature of the transaction Purchase of Ordinary Shares  c.  Price(s) and volume(s) 2.81 pence 400,000 Ordinary Shares d.  Aggregated information · Aggregated volume · Price   N/A e.  Date of the transaction 15 September 2022 f.  Place of the transaction London Stock Exchange  

View stock analysis, news, and events for Cambridge Nutritional Sciences Plc